Studies, News and More

Published Studies

Rethinking Glaucoma Management Using Wearable Diagnostics From Heru
re:Vive™ Visual Field

July 25, 2021 – Heru

Rethinking Glaucoma Management
Heru’s Advancements Of Visual Field Testing For Glaucoma

July 30, 2021 – Heru

re:Imagine™ Vision Diagnostics with Heru.

July 30, 2021 – Heru

Mobility improvement of patients with peripheral visual field losses using novel see-through digital spectacles

October 14, 2020 – PLoS One

Press Releases

Heru, the Wearable Diagnostic and Vision Augmentation Leader, Bolsters Executive Team with Seasoned Industry Veterans

July 13, 2021

Heru Series A Funding Accelerates Cloud and Artificial Intelligence-Enabled Wearable Vision Diagnosis and Therapy

May 20, 2021

Medical Technology Company Heru, Inc. Completes FDA Registration Following a $2.7M Seed Round

December 21, 2020

In the News

Heru registers AI vision test with FDA, begins commercialization pilot

December 28, 2020 – BioWorld

Medical technology company Heru, Inc completes FDA registration following a $2.7M seed round

December 22, 2020 – Ophthalmology360

Cloud-based augmented/virtual reality platform receives class I listing with FDA

December 21, 2020 – Ophthalmology Times

Be the first to know

Receive product updates and get early access to Heru technologies.